Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

People with alopecia areata have higher levels of a heart disease marker in their blood.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Classical PCOS types A and B are most common and linked to higher health risks.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hirsutism and acne indicate high androgen levels in women with PCOS, suggesting early treatment can help.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

CTP-543 is generally safe for treating alopecia areata.

Insulin resistance is linked to higher hormone levels in women with PCOS.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Higher socioeconomic status improves quality of life and mental health in women with PCOS-like symptoms.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

aPKCλ is essential for hair follicle stem cell maintenance and wound healing.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

A 13-year-old boy with Cushing syndrome has high cortisol levels from a pituitary gland issue and underdeveloped sexual characteristics.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.